Drug Fix: Post-Mortem On Martin Makary’s Tenure As FDA Commissioner

Pink Sheet Executive Editor Derrick Gingery, Senior Reporter Maaisha Osman, Senior Editor Sue Sutter, Editor-in-Chief Nielsen Hobbs, as well as special guest Mike McCaughan, founding member of Prevision Policy, discuss the circumstances and mistakes that lead to Martin Makary’s resignation as head of the US Food and Drug Administration (:38), his achievements during his short term (21:56), the agency’s way forward (29:12) and the pressure on the Trump Administration pick the correct replacement (36:35). More On These Topics From The Pink Sheet Makary’s Exit Resurrects Questions About US FDA’s Direction Under Trump Administration: PhRMA CEO Backs Parts Of Makary’s US FDA Agenda As Diamantas’ Onboarding Continues: What Does Declining Average Commissioner Term Length Say About US FDA’s Future?: Trump Plan To Oust Makary Clouds Future Of ‘Bold Reforms’ At US FDA:

You can listen to Drug Fix: Post-Mortem On Martin Makary’s Tenure As FDA Commissioner online on Radio and Podcast. Open the player on this page to stream the available audio.

Drug Fix: Post-Mortem On Martin Makary’s Tenure As FDA Commissioner is an episode from Pharma Intelligence Podcasts.

This episode is 40:25 long.

This episode was published on May 15, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Pharma Intelligence Podcasts when more episodes are available from the podcast feed.